BridgeMD
New treatment option for Anxiety
Official title Role of Parent Interpretation Bias in the Transmission of Anxiety to Children
ClinicalTrials.gov ID: NCT05665491
What this study is testing
- What it's testing
- Approximately 30% of children will experience an anxiety disorder, making anxiety the most common mental health problem among children in the United States. However, few children receive treatment and even our most effective anxiety treatments leave up to half of children in need of additional intervention.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 and older
You may be able to join if
- for parent participants are:
- Must have an ability to speak and understand English sufficiently to complete assessments
- At least minimal anxiety severity (GAD-7 score \> 5)
- At least a minimal level of interpretation bias (WSAP overall accuracy less than 70%)
- No current psychiatric symptoms that would interfere with the individual's ability to provide consent or complete the research procedures
See the full eligibility criteria
- for parent participants are:
- Must have an ability to speak and understand English sufficiently to complete assessments
- At least minimal anxiety severity (GAD-7 score \> 5)
- At least a minimal level of interpretation bias (WSAP overall accuracy less than 70%)
- No current psychiatric symptoms that would interfere with the individual's ability to provide consent or complete the research procedures
- If receiving treatment, stable on medications or psychotherapy for 8 weeks
- No severe suicidal ideation (PHQ-9 item 9 \> 1)
- Own iOS or Android smartphone
- Shared or full custody of child (for EMA assessment of parenting behaviors) for child participants are:
- Age 7 to 12
- Must have an ability to speak and understand English sufficiently to complete assessments
- No diagnosis of intellectual disability or autism spectrum disorder (per parent or clinician report)
- No current psychiatric symptoms that would prevent informed consent or understanding of research procedures
- Wechsler Abbreviated Scale of Intelligence (WASI) full-scale IQ equal to or greater than 80 to ensure understanding of study procedures
- If receiving treatment, stable on medications or psychotherapy for 8 weeks
- No severe suicidal ideation (PHQ-9 item 9 \> 1)
The study team makes the final eligibility decision.
Where it's taking place
- Belmont, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Belmont, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.